VVOS
Vivos Therapeutics Inc
NASDAQ: VVOS · HEALTHCARE · MEDICAL DEVICES
$0.80
+2.26% today
Updated 2026-04-30
Market cap
$11.46M
P/E ratio
—
P/S ratio
0.66x
EPS (TTM)
$-2.07
Dividend yield
—
52W range
$1 – $8
Volume
0.2M
Vivos Therapeutics Inc (VVOS) Financial statements
SEC filings — annual and quarterly data.
Profit margin
-121.40%
Operating margin
-166.90%
ROE
-663.00%
ROA
-61.50%
Debt/equity
—
Margin trends — annual
Gross margin Operating margin Profit margin
| Year | Revenue | Net income | Gross margin | Op. margin | Profit margin |
|---|---|---|---|---|---|
| 2018 | $3.79M | $-8.44M | 71.48% | -219.82% | -222.54% |
| 2019 | $11.39M | $-10.75M | 75.99% | -92.84% | -94.39% |
| 2020 | $13.07M | $-12.06M | 79.70% | -92.15% | -92.28% |
| 2021 | $16.89M | $-20.29M | 74.65% | -115.32% | -120.15% |
| 2022 | $16.02M | $-23.84M | 62.52% | -156.21% | -148.81% |
| 2023 | $13.80M | $-13.58M | 59.93% | -125.32% | -98.42% |
| 2024 | $15.03M | $-11.14M | 60.00% | -74.32% | -74.09% |
| 2025 | $17.44M | $-21.23M | 60.44% | -114.05% | -121.71% |